71 related articles for article (PubMed ID: 23314309)
1. PDCD4 functions as a suppressor for pT2a and pT2b stage gastric cancer.
Guo PT; Yang D; Sun Z; Xu HM
Oncol Rep; 2013 Mar; 29(3):1007-12. PubMed ID: 23314309
[TBL] [Abstract][Full Text] [Related]
2. The expression of ARHI in pT2a and pT2b stage gastric cancer and its clinical significance.
Wang W; Bu XM; Wang J; Zhang N; Zhao CH
Oncol Rep; 2012 Jun; 27(6):1953-9. PubMed ID: 22427032
[TBL] [Abstract][Full Text] [Related]
3. Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status (pN).
Park DJ; Kong SH; Lee HJ; Kim WH; Yang HK; Lee KU; Choe KJ
Surgery; 2007 Jun; 141(6):757-63. PubMed ID: 17560252
[TBL] [Abstract][Full Text] [Related]
4. Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer.
Iwaya T; Fukagawa T; Suzuki Y; Takahashi Y; Sawada G; Ishibashi M; Kurashige J; Sudo T; Tanaka F; Shibata K; Endo F; Katagiri H; Ishida K; Kume K; Nishizuka S; Iinuma H; Wakabayashi G; Mori M; Sasako M; Mimori K
Clin Cancer Res; 2013 Dec; 19(23):6438-49. PubMed ID: 24097871
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression.
Wang W; Zhao J; Wang H; Sun Y; Peng Z; Zhou G; Fan L; Wang X; Yang S; Wang R; Fang D
Exp Cell Res; 2010 Sep; 316(15):2456-64. PubMed ID: 20595005
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of subclassification of pT2 gastric cancer: a retrospective study of 847 patients.
Lu Y; Liu C; Zhang R; Li H; Lu P; Jin F; Xu H; Wang S; Chen J
Surg Oncol; 2008 Dec; 17(4):317-22. PubMed ID: 18586486
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers.
Kakimoto T; Shiraishi R; Iwakiri R; Fujimoto K; Takahashi H; Hamajima H; Mizuta T; Ideguchi H; Toda S; Kitajima Y; Ozaki I; Matsuhashi S
Oncol Rep; 2011 Dec; 26(6):1385-92. PubMed ID: 21894439
[TBL] [Abstract][Full Text] [Related]
9. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
11. Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.
Bilici A; Dane F; Seker M; Ustaalioglu BB; Aliustaoglu M; Temiz S; Gezen C; Yavuzer D; Aksu G; Mayadagli A; Gumus M; Uygun K; Turhal NS
Dig Dis Sci; 2011 Nov; 56(11):3226-34. PubMed ID: 21660487
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.
Motoyama K; Inoue H; Mimori K; Tanaka F; Kojima K; Uetake H; Sugihara K; Mori M
Int J Oncol; 2010 May; 36(5):1089-95. PubMed ID: 20372781
[TBL] [Abstract][Full Text] [Related]
13. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
14. [The clinical value of further accurate staging of pT2 gastric cancer based on the depth of invasion].
Ding PA; Yang PG; Tian Y; Li F; Guo HH; Liu Y; Zhang ZD; Wang D; Li Y; Zhao Q
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1197-1202. PubMed ID: 34794224
[No Abstract] [Full Text] [Related]
15. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
16. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
18. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
